Rezultati pretrage - Seok‐Goo Cho

Detaljiziraj rezultate
  1. 1
    Clinical applications of mesenchymal stem cells

    Clinical applications of mesenchymal stem cells od Nayoun Kim, Seok‐Goo Cho

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications

    Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications od Nayoun Kim, Seok‐Goo Cho

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    New Strategies for Overcoming Limitations of Mesenchymal Stem Cell-Based Immune Modulation

    New Strategies for Overcoming Limitations of Mesenchymal Stem Cell-Based Immune Modulation od Nayoun Kim, Seok‐Goo Cho

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation

    The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation od Eun Jung Kim, Nayoun Kim, Seok‐Goo Cho

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Case Report: A case series on histiocytic sarcoma – various clinical features and patient outcomes

    Case Report: A case series on histiocytic sarcoma – various clinical features and patient outcomes od Hohyung Nam, Gi June Min, Tong Yoon Kim, Young‐Woo Jeon, Seok‐Goo Cho

    Izdano 2025
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis

    Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis od Jung-Yeon Lim, Keon-Il Im, Eunsol Lee, Nayoun Kim, Young-Sun Nam, Young‐Woo Jeon, Seok‐Goo Cho

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release

    The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release od Keon-Il Im, Nayoun Kim, Jung-Yeon Lim, Young-Sun Nam, Eunsol Lee, Eunjung Kim, Hyoung Jin Kim, Soon Ha Kim, Seok‐Goo Cho

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    B cell-associated immune profiles in patients with end-stage renal disease (ESRD)

    B cell-associated immune profiles in patients with end-stage renal disease (ESRD) od Kyoung‐Woon Kim, Byung Ha Chung, Eun Joo Jeon, Bo‐Mi Kim, Bum Soon Choi, Cheol Whee Park, Yong‐Soo Kim, Seok‐Goo Cho, Mi‐La Cho, Chul Woo Yang

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab

    Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab od Frits van Rhee, Jean‐François Rossi, David Simpson, Alexander Fosså, Angela Dispenzieri, John Kuruvilla, Yeow Tee Goh, Seok‐Goo Cho, Marcelo Capra, Ting Liu, Corey Casper, James Cavet, Raymond Wong

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  10. 10
    Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy

    Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy od Jae‐Ho Yoon, Sung‐Soo Park, Young‐Woo Jeon, Sung‐Eun Lee, Byung-Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Jong Wook Lee

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Double Step-up Dosing (2SUD) Regimen Mitigates Severe Icans and CRS While Maintaining High Efficacy in Subjects with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL) Treated with AZD0486, a Novel CD19xCD3 T-Cell Engager (TCE): Updated Safety and Efficacy Data from the Ongoing First-in-Human (FIH) Phase 1 Trial

    Double Step-up Dosing (2SUD) Regimen Mitigates Severe Icans and CRS While Maintaining High Efficacy in Subjects with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL) Tre... od Sameh Gaballa, Ranjit Nair, Ryan Jacobs, Sumana Devata, Seok‐Goo Cho, Don A. Stevens, Dok Hyun Yoon, Nirav N. Shah, Denise Brennan, Jason Law, Robert Chen, David Sermer, Robin Lesley, Ben Buelow, Alessandra Forcina, Jing‐Zhou Hou

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation

    Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation od Byung‐Sik Cho, Seung‐Ah Yahng, Sung‐Eun Lee, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Dong-Wook Kim, Jong‐Wook Lee, Woo-Sung Min, Chong-Won Park

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study od Simon Rule, Wojciech Jurczak, Mats Jerkeman, C. Rusconi, Marek Trněný, Fritz Offner, Dolores Caballero, Cristina João, Mathias Witzens‐Harig, Georg Heß, Isabelle Bence‐Bruckler, Seok‐Goo Cho, Catherine Thiéblemont, Wangchi Zhou, Todd Henninger, Judith D. Goldberg, Jessica Vermeulen, Martin Dreyling

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

    Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludar... od Seung‐Hwan Shin, Young‐Woo Jeon, Jee-Hyun Yoon, Seung‐Ah Yahng, S E Lee, B S Cho, Ki‐Seong Eom, Y J Kim, Sae-Mi Lee, Chang‐Ki Min, H J Kim, Seok‐Goo Cho, D W Kim, W S Min, Jung Woo Lee

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

    Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study od Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trněný, Fritz Offner, Dolores Caballero, Cristina João, Mathias Witzens‐Harig, Georg Heß, Isabelle Bence‐Bruckler, Seok‐Goo Cho, John Bothos, Jeffrey L. Goldberg, Christopher Enny, Shana Traina, Sriram Balasubramanian, Nibedita Bandyopadhyay, Steven Sun, Jessica Vermeulen, Aleksandra Rizo, Simon Rule

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates

    WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and... od Byung‐Sik Cho, Gi June Min, Sungsu Park, Seung‐Hwan Shin, Seung‐Ah Yahng, Young‐Woo Jeon, Jae‐Ho Yoon, Sung‐Eun Lee, Ki‐Seong Eom, Yoo‐Jin Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong‐Wook Lee, Myungsin Kim, Young-Gu Kim, Hee‐Je Kim

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs

    Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs od Seok‐Goo Cho, Nayoun Kim, Hyun‐Jung Sohn, Suk Kyeong Lee, Sang Taek Oh, Hyun-Joo Lee, Hyun-Il Cho, Hyeon Woo Yim, Seung Eun Jung, Gyeongsin Park, Joo Hyun Oh, Byung‐Ock Choi, Sung Won Kim, Soo Whan Kim, Nak Gyun Chung, Jong Wook Lee, Young Seon Hong, Tai‐Gyu Kim

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease

    Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease od Sung‐Eun Lee, Ji‐Young Lim, Da‐Bin Ryu, Tae‐Woo Kim, Sung Soo Park, Young‐Woo Jeon, Jae‐Ho Yoon, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Seok‐Goo Cho, Dong‐Wook Kim, Jong Wook Lee, Chong-Su Kim, Dong‐Mi Shin, Chang‐Ki Min

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

    Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study od Huiqiang Huang, Jun Zhu, Ming Yao, Tae Min Kim, Dok Hyun Yoon, Seok‐Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su-Peng Yeh, Yuqin Song, Yok‐Lam Kwong, Jin Seok Kim, Jie Jin, Yuankai Shi, Hye‐Jin Kim, Qing Min, Tianyuan Zhou, Grace Gao, Zong-qi Dong, Ming Qi, Won Seog Kim

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

    Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) od Sabarish Ayyappan, Won Seog Kim, Tae Min Kim, Jan Walewski, Seok‐Goo Cho, Isidro Jarque, Elżbieta Iskierka‐Jażdżewska, Michelle Poon, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran‐Der Tan, Antonio Gutiérrez, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoît Tessoulin, Jingjin Li, Melanie Ufkin, Saleem Shariff, Lei Chi, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, H. Miles Prince

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: